产品中心
产品型号:Mouse G-CSF protein
更新时间:2025-06-23
厂商性质:生产厂家
访问量:103
86-027-59716789
产品英文名称 | Mouse G-CSF protein |
产品中文名称 | 重组小鼠粒细胞集落刺激因子(G-CSF) |
别名 | G-CSF; Colony Stimulating Factor 3; Granulocyte; GCSF |
标签 | 无标签 |
表达宿主 | 大肠杆菌 |
种属 | 小鼠 |
序列 | 氨基酸序列来源于:重组小鼠粒细胞集落刺激因子(G-CSF) (P09920) (V31-A208) 表达的蛋白片段。 |
活性 | 通过其诱导M-NFS-60细胞增殖的能力来测定。ED50为2.038 pg/mL。 |
蛋白长度 | 重组小鼠粒细胞集落刺激因子(G-CSF) 由178个氨基酸组成,预测分子量为18.95 KD。 |
纯度 | > 99% ,使用SDS-PAGE检测 |
特点&优势 | 通过LAL法测定,每微克蛋白里内毒素含量<1.0>1.0> |
产品形式 | 冻干粉,冻干缓冲液为无菌的20 mM Tris,150 mM NaCl,pH 7.4。 |
基因ID | 12985 |
蛋白序列链接 | /uniprotkb/P09920/entry |
使用中注意事项 | 开盖使用前,请先离心。本产品为冻干粉,推荐用该产品配套的Reconstitution Buffer进行复溶,且浓度不低于100 µg/mL。客户可根据后续的实验需求,进行进一步的稀释。 |
保存建议 | 本产品为冻干粉形式,建议:将冻干粉产品保存于-20℃以下的干燥环境中。本产品溶解之后,可在4℃保存2-7天,长期使用请置于-20℃以下。为长期保存,推荐添加载体蛋白(0.1% HAS/BSA或12%FBS),并酌情分装保存,避免反复冻融。 |
运输条件 | 冰袋运输(蓝冰) |
警告 | 本文列出的产品仅供研究使用,不适用于人类或临床诊断。我们产品所推荐应用,不是建议使用我们的产品去违反任何或许可证。对于使用本产品可能发生的侵权或其他违规行为,我们不承担任何责任。 |
背景 | Granulocyte-colony stimulating factor (G-CSF) is a growth factor and an essential cytokine belonging to the CSF family of hormone-like glycoproteins. It is produced by numerous cell types including immune and endothelial cells. G-CSF binding to its receptor G-CSF-R which belongs to the cytokine receptor type I family depends on the interaction of alpha-helical motifs of the former and two fibronectin type III as well as an immunoglobulin-like domain of the latter. Recent animal studies have also revealed that G-CSF activates multiple signaling pathways, such as Akt and also the Janus family kinase-2 and signal transducer and activation of transcription-3 (Jak2-STAT3) pathway, thereby promoting survival, proliferation, differentiation and mobilisation of haematopoietic stem and progenitor cells. G-CSF is a cytokine that have been demonstrated to improve cardiac function and perfusion in myocardial infarction. And it was initially evaluated as a stem cell mobilizer and erythropoietin as a cytoprotective agent. G-CSF prevents left ventricular remodeling after myocardial infarction by decreasing cardiomyocyte death and by increasing the number of blood vessels, suggesting the importance of direct actions of G-CSF on the myocardium rather than through mobilization and differentiation of stem cells. Accordingly, recombinant human (rh)G-CSF has been extensively used in clinical haematology and oncology to enable bone marrow transplantation or to treat chemotherapy-associated neutropenia. In preclinical study, G-CSF improved cardiac function and perfusion by angiomyogenesis and protection of cardiomyocytes in myocardial infarction. |
Fig.Mouse G-CSF protein